NLRP3 and periodontitis: In turn, it has been hypothesized that periodontitis, in patients with type-II DM, may contribute, through its chronic inflammatory effects supported by an abundant oral microflora, to a further upregulation of the salivary and serum NLRP3 concentrations (Isola et al., 2022).